WASHINGTON, Aug 20 (Reuters) - The U.S. Centers for Medicare & Medicaid Services, in a notice posted on its website:
* Sets March 24, 2010 meeting to review evidence on the use of ESA anemia drugs in patients with chronic kidney disease
* ESA anemia drugs include Johnson & Johnson's Procrit, Amgen's Aranesp
(Company news desk in Washington; +1 202 898 8400, washington.newsroom@reuters.com) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Sets March 24, 2010 meeting to review evidence on the use of ESA anemia drugs in patients with chronic kidney disease
* ESA anemia drugs include Johnson & Johnson's Procrit, Amgen's Aranesp
(Company news desk in Washington; +1 202 898 8400, washington.newsroom@reuters.com) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.